Dr. Agrawal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
New York, NY 10021Phone+1 212-746-9663Fax+1 212-746-3609
Education & Training
- Stanford University School of MedicineClass of 2019
Certifications & Licensure
- NY State Medical License 2022 - 2027
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.Prashasti Agrawal, Michael Offin, Victoria Lai, Michelle S Ginsberg, Prasad S Adusumilli
JTO Clinical and Research Reports. 2025-01-01 - 13 citationsOlder patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin
American Journal of Hematology. 2023-06-01 - 4 citationsEBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim
Leukemia & Lymphoma. 2023-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: